Clinical Trial Update: Molecular HistoMx Assessment for Kidney Transplant Rejection and Management

View source ↗

Summary

This clinical trial evaluating Molecular HistoMx for detecting and managing kidney transplant rejection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Snippet

Sponsor: Paris Translational Research Center for Organ Transplantation | Conditions: Graft Rejection | Status: COMPLETED